Why is Sudeep Pharma Ltd falling/rising?

As of 20-Jun, Sudeep Pharma Ltd's stock price is currently at 844.25, reflecting a decrease of 5.55 points or 0.65%. The stock has been experiencing a decline, having fallen consecutively for the last two days, resulting in a total loss of 3.3% during this period. Additionally, the stock has underperformed its sector by 1.53% today.Despite these recent declines, Sudeep Pharma has shown strong performance over longer periods, with a 12.64% increase over the past week and a significant 30.38% rise over the past month. Year-to-date, the stock has gained 40.14%, contrasting sharply with the Sensex, which has decreased by 9.88% in the same timeframe. However, there are signs of falling investor participation, as evidenced by a substantial drop in delivery volume, which fell by 66.76% compared to the 5-day average. This decline in trading activity may contribute to the stock's recent price drop. Furthermore, while the stock is trading above its moving averages, the current performance indicates a potential consolidation phase after a strong upward trend earlier in the year. Overall, the combination of recent price declines, reduced trading volume, and underperformance against the sector are contributing factors to the current falling price of Sudeep Pharma Ltd.

Which are the latest news on Sudeep Pharma?

Sudeep Pharma Ltd Gains 12.64%: 5 Key Factors Driving the Surge Sudeep Pharma Ltd is Rated Hold by MarketsMOJO

What does Sudeep Pharma do?

Overview: Sudeep Pharma Ltd operates in the Pharmaceuticals & Biotechnology industry and is categorized as a Small Cap company.History: The incorporation year and any status changes are not provided. The latest quarterly results report net sales and profit for the period ending March 2026.Financial Snapshot: Most recent Net Sales: 182 Cr (Quarterly Results - Mar 2026) Most recent Net Profit: 49 Cr (Quarterly Results - Mar 2026) Market-cap value: INR 8,550 Cr (Small Cap)Key Metrics: P/E: 48.00 Industry P/E: 34 Dividend Yield: 0.00% Debt-Equity: 0.04 Return on Equity: 19.57% Price to Book: 9.47Contact Details: Registrar Address: Not available. Phone: N/A Email: N/A Website: N/A

How big is Sudeep Pharma?

As of 10th June, Market Cap: Sudeep Pharma Ltd has a market capitalization of 8,550.00 Cr, classifying it as a Small Cap company.Recent Quarterly Performance: The sum of Net Sales for the latest 4 quarters is 642.27 Cr, while the sum of Net Profit for the same period is 172.90 Cr.Balance Sheet Snapshot: The reporting period for the balance sheet is March 2025. Shareholder's Funds are valued at 493.09 Cr, and Total Assets amount to 716.85 Cr.

Who are the peers of the Sudeep Pharma?

Peers: The peers of Sudeep Pharma are Sanofi Consumer, P & G Health Ltd, Akums Drugs, Strides Pharma, Blue Jet Health, Supriya Lifesci., Sanofi India, SPARC, and FDC.Quality Snapshot: Excellent management risk is observed at Sanofi Consumer, P & G Health Ltd, and Sanofi India, while Good management risk is found at Blue Jet Health and Supriya Lifesci., and the rest have Average management risk. All peers exhibit Below Average growth except for SPARC, which has Excellent growth, while Akums Drugs, Strides Pharma, Blue Jet Health, Supriya Lifesci., Sanofi India, and FDC show Below Average growth. Excellent capital structure is noted at Sanofi Consumer, P & G Health Ltd, Blue Jet Health, Supriya Lifesci., and FDC, while Good capital structure is found at Akums Drugs, Average capital structure is seen at Strides Pharma and SPARC, and the rest have Below Average capital structure.Return Snapshot: Supriya Lifesci. has the highest 1-year return at 42.25%, while Sanofi India has the lowest at -48.76%, with Sudeep Pharma's 1-year return being N/A. Additionally, Sanofi India and FDC have negative six-month returns.

SUDEEPPHRM Share Price | Sudeep Pharma Ltd Stock Analysis & Recommendation

Key Events This Week

15 Jun: New 52-week and all-time highs at Rs.820.7 and Rs.824.45 respectively

16 Jun: Stock hits fresh 52-week and all-time highs at Rs.857.1 and Rs.856.10

17 Jun: New 52-week and all-time highs at Rs.874.75 and Rs.860.55

18 Jun: Price correction with a 2.51% decline to Rs.849.80

19 Jun: Week closes at Rs.844.25, down 0.65% on the day

Week Open

Read full news article

Sudeep Pharma Ltd is Rated Hold by MarketsMOJO

Sudeep Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 22 May 2026. While the rating was assigned on that date, the analysis and financial metrics discussed here reflect the stock's current position as of 19 June 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Broad-Based Technical Strength Lifts Sudeep Pharma Ltd to 52-Week High of Rs 874.75

Surging past its previous peaks, Sudeep Pharma Ltd touched a new 52-week high of Rs 874.75 on 17 Jun 2026, propelled by a confluence of bullish technical indicators and sustained price momentum over recent sessions.

Read full news article

[ { "link": "quarterly", "btn_text": "All Quarterly Results", "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ", "rhs": [ { "prefix": "Net Sales ", "suffix": "QoQ Growth in quarter ended Mar 2026 is -11.20% vs 2.73% in Dec 2025", "dir": -1 }, { "prefix": "Standalone Net Profit ", "suffix": "QoQ Growth in quarter ended Mar 2026 is -4.09% vs -9.65% in Dec 2025", "dir": 1 } ], "table": { "header": [ "Mar'26", "Dec'25", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "80.17", "val2": "90.28", "chgp": "-11.20%", "chgp_class": "negative" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "28.89", "val2": "29.61", "chgp": "-2.43%", "chgp_class": "negative" }, { "field": "Interest", "val1": "1.97", "val2": "0.63", "chgp": "212.70%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "25.77", "val2": "26.87", "chgp": "-4.09%", "chgp_class": "negative" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "36.04%", "val2": "32.80%", "chgp": "3.24%", "chgp_class": "positive" } ] } }, { "link": "half-yearly", "btn_text": "All Half Yearly Results", "header": "Half Yearly Results Snapshot (Standalone) - Sep'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Sep'25", "Sep'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "168.06", "val2": "168.40", "chgp": "-0.20%", "chgp_class": "negative" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "61.27", "val2": "60.03", "chgp": "2.07%", "chgp_class": "positive" }, { "field": "Interest", "val1": "3.47", "val2": "1.99", "chgp": "74.37%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "54.95", "val2": "41.98", "chgp": "30.90%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "36.46%", "val2": "35.65%", "chgp": "0.81%", "chgp_class": "positive" } ] } }, { "link": "nine-monthly", "btn_text": "All Nine Monthly Results", "header": "Nine Monthly Results Snapshot (Standalone) - Dec'25", "rhs": [ { "prefix": "Net Sales ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 }, { "prefix": "Standalone Net Profit ", "suffix": "Not Applicable: The company has declared_date for only one period", "dir": 0 } ], "table": { "header": [ "Dec'25", "Dec'24", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "258.34", "val2": "251.88", "chgp": "2.56%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "90.88", "val2": "86.49", "chgp": "5.08%", "chgp_class": "positive" }, { "field": "Interest", "val1": "4.10", "val2": "3.24", "chgp": "26.54%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Standalone Net Profit", "val1": "81.82", "val2": "62.61", "chgp": "30.68%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "35.18%", "val2": "34.34%", "chgp": "0.84%", "chgp_class": "positive" } ] } }, { "link": "annual", "btn_text": "All Annual Results", "header": "Annual Results Snapshot (Consolidated) - Mar'26", "rhs": [ { "prefix": "Net Sales ", "suffix": "YoY Growth in year ended Mar 2026 is 27.94% vs 9.30% in Mar 2025", "dir": 1 }, { "prefix": "Consolidated Net Profit ", "suffix": "YoY Growth in year ended Mar 2026 is 24.62% vs 4.16% in Mar 2025", "dir": 1 } ], "table": { "header": [ "Mar'26", "Mar'25", "Change(%)" ], "body": [ { "field": "Net Sales", "val1": "642.26", "val2": "502.00", "chgp": "27.94%", "chgp_class": "positive" }, { "field": "Operating Profit (PBDIT) excl Other Income", "val1": "221.91", "val2": "189.95", "chgp": "16.83%", "chgp_class": "positive" }, { "field": "Interest", "val1": "7.60", "val2": "5.85", "chgp": "29.91%", "chgp_class": "negative" }, { "field": "Exceptional Items", "val1": "0.00", "val2": "0.00", "chgp": "", "chgp_class": "neutral" }, { "field": "Consolidate Net Profit", "val1": "172.89", "val2": "138.73", "chgp": "24.62%", "chgp_class": "positive" }, { "field": "Operating Profit Margin (Excl OI)", "val1": "34.55%", "val2": "37.84%", "chgp": "-3.29%", "chgp_class": "negative" } ] } } ]